MercantepeFBaydur SahinSCumhur CureM, et al.Relationship between serum endocan levels and other predictors of endothelial dysfunction in obese women. Angiology. 2023;74(10):948.
2.
LvYZhangYShiW, et al.The association between endocan levels and subclinical atherosclerosis in patients with type 2 diabetes mellitus. Am J Med Sci. 2017;353(5):433.
3.
BehnoushAHKhalajiABahiraieP, et al.Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis. Hypertens Res. 2023;46(10):2388.
4.
KlisićAKavarićNSpasojević-KalimanovskaV, et al.Serum endocan levels in relation to traditional and non-traditional anthropometric indices in adult population. J Med Biochem. 2021;40(1):41–48.
5.
BehnoushAHKhalajiABahiraieP, et al.Endocan as a marker of endothelial dysfunction in hypertension: a systematic review and meta-analysis. Hypertens Res. 2023;46(10):2388.
6.
HeinTWSinghUVasquez-VivarJ, et al.Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis. 2009;206(1):61.
7.
BaltaSMikhailidisDPDemirkolS, et al.Endocan: a novel inflammatory indicator in cardiovascular disease?Atherosclerosis. 2015;243(1):339.
8.
MoraceCCuratolaSLMandraffinoG, et al.Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients. Ital J Pediatr. 2023;49(1):108.
